Dr. Andres Ferber, MD

Dr. Ferber practices at Jefferson Stratford Hospital in Stratford, New Jersey, part of Thomas Jefferson University.

Dr. Ferber's NPI, 1841213048, was assigned on July 26, 2006. Dr. Ferber graduated from Universidad de la República - Facultad de Medicina in 1988. Dr. Ferber holds New Jersey license MA08228700.

Dr. Ferber's primary practice is Jefferson Stratford Hospital, at 18 East Laurel Road, Stratford, NJ 08084 in Camden County. The practice phone is (856) 346-7802.

Dr. Ferber's primary practice is Jefferson Stratford Hospital in Stratford, New Jersey, part of Thomas Jefferson University. Dr. Ferber is also affiliated with Cooper University Hospital. The medical group on file is Richboro Medical. Dmand AI also links Dr. Ferber to 2 more hospitals, 4 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ferber practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ferber's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ferber is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Ferber's licenses on file in 2 states: New Jersey and Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, deep vein thrombosis (DVT), fluid and electrolyte imbalances, immune deficiency disease and lung cancer among the conditions Dr. Ferber treats.

CMS data shows 647 Medicare services from Dr. Ferber across 7 procedure codes in 2024, for 251 Medicare patients. Medicare paid $60,780 for them.

CMS counts 251 Medicare patients who saw Dr. Ferber in 2024. The largest group is 65 to 74, with 104 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ferber's median patient age at 72, with 55% women.

In 2024, Dr. Ferber wrote 802 Medicare Part D claims for 121 patients. 69% of them were for generic drugs. CMS names the drug for 610 of them, across 24 drugs with 11 or more claims each, at $2,640,118 in total drug cost. In 2023, CMS named 415 claims across 20 drugs.

Dr. Ferber accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ferber as offering telehealth.

Dmand AI links 27 papers to Dr. Ferber, published from 2009 to 2025. 2024 was the busiest year, with 3. The most frequent topics are Molecular Sequence Data, Base Sequence and Cell Division. Dr. Ferber has published most often in Biol Blood Marrow Transplant. Dr. Ferber's most frequent co-authors are Kamyar Nader, MD, Danielle Lajoie Behrens, DO and Tulin Budak-Alpdogan, MD.

Dmand AI links Dr. Ferber to 1 clinical trial. Conditions studied include Leukemia, Myeloid, Acute and Leukemia, Myeloid.

CMS Open Payments shows 15 general payments to Dr. Ferber from 9 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $165.

Dmand AI lists 4 awards for Dr. Ferber, most recently Inside Jersey Magazine Top Doctors in 2014.

Dr. Ferber graduated from Universidad de la República - Facultad de Medicina in 1988. Dr. Ferber is a member of ASCO and ASH.

Dr. Ferber is in network with 21 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.